Keywords: Lundbeck, ImaginAb, Neurodegeneration collaboration, CNS, BBB transport of biologics

Lundbeck in neurodegeneration collaboration with ImaginAb

Article | 09 October 2012

Print This

ImaginAb Inc, a clinical-stage US company developing in vivo molecular imaging agents based on antibody fragment technology, has entered into ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in